# A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

> **NCT05396391** · PHASE1,PHASE2 · UNKNOWN · sponsor: **SUNHO（China）BioPharmaceutical CO., Ltd.** · enrollment: 140 (estimated)

## Conditions studied

- Advanced Malignant Tumors

## Interventions

- **DRUG:** IAP0971

## Key facts

- **NCT ID:** NCT05396391
- **Lead sponsor:** SUNHO（China）BioPharmaceutical CO., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-22
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05396391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05396391, "A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05396391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*